119 related articles for article (PubMed ID: 21447639)
21. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
[TBL] [Abstract][Full Text] [Related]
22. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
Abermil N; Guillaud-Bataille M; Burnichon N; Venisse A; Manivet P; Guignat L; Drui D; Chupin M; Josseaume C; Affres H; Plouin PF; Bertherat J; Jeunemaître X; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2012 May; 97(5):E805-9. PubMed ID: 22419703
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas.
Aguiar RC; Cox G; Pomeroy SL; Dahia PL
J Clin Endocrinol Metab; 2001 Jun; 86(6):2890-4. PubMed ID: 11397905
[TBL] [Abstract][Full Text] [Related]
24. Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
Nölting S; Grossman AB
Endocr Pathol; 2012 Mar; 23(1):21-33. PubMed ID: 22391976
[TBL] [Abstract][Full Text] [Related]
25. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
Santarpia L; Habra MA; Jiménez C
Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
[TBL] [Abstract][Full Text] [Related]
26. Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation.
Toledo SP; Lourenço DM; Sekiya T; Lucon AM; Baena ME; Castro CC; Bortolotto LA; Zerbini MC; Siqueira SA; Toledo RA; Dahia PL
J Clin Endocrinol Metab; 2015 Feb; 100(2):E308-18. PubMed ID: 25389632
[TBL] [Abstract][Full Text] [Related]
27. Novel mutation in the TMEM127 gene associated with phaeochromocytoma.
Elston MS; Meyer-Rochow GY; Prosser D; Love DR; Conaglen JV
Intern Med J; 2013 Apr; 43(4):449-51. PubMed ID: 23551308
[TBL] [Abstract][Full Text] [Related]
28. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
[TBL] [Abstract][Full Text] [Related]
29. TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.
Guo Q; Cheng ZM; Gonzalez-Cantú H; Rotondi M; Huelgas-Morales G; Ethiraj P; Qiu Z; Lefkowitz J; Song W; Landry BN; Lopez H; Estrada-Zuniga CM; Goyal S; Khan MA; Walker TJ; Wang E; Li F; Ding Y; Mulligan LM; Aguiar RCT; Dahia PLM
Cell Rep; 2023 Sep; 42(9):113070. PubMed ID: 37659079
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
32. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
Mannelli M; Castellano M; Schiavi F; Filetti S; Giacchè M; Mori L; Pignataro V; Bernini G; Giachè V; Bacca A; Biondi B; Corona G; Di Trapani G; Grossrubatscher E; Reimondo G; Arnaldi G; Giacchetti G; Veglio F; Loli P; Colao A; Ambrosio MR; Terzolo M; Letizia C; Ercolino T; Opocher G;
J Clin Endocrinol Metab; 2009 May; 94(5):1541-7. PubMed ID: 19223516
[TBL] [Abstract][Full Text] [Related]
33. Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients.
Perren A; Barghorn A; Schmid S; Saremaslani P; Roth J; Heitz PU; Komminoth P
Oncogene; 2002 Oct; 21(49):7605-8. PubMed ID: 12386824
[TBL] [Abstract][Full Text] [Related]
34. Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas.
Remacha L; Comino-Méndez I; Richter S; Contreras L; Currás-Freixes M; Pita G; Letón R; Galarreta A; Torres-Pérez R; Honrado E; Jiménez S; Maestre L; Moran S; Esteller M; Satrústegui J; Eisenhofer G; Robledo M; Cascón A
Clin Cancer Res; 2017 Oct; 23(20):6315-6324. PubMed ID: 28720665
[No Abstract] [Full Text] [Related]
35. Paragangliomas in patients with mutations of the SDHD gene.
Boedeker CC; Neumann HP; Ridder GJ; Maier W; Schipper J
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):467-70. PubMed ID: 15746863
[TBL] [Abstract][Full Text] [Related]
36. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
38. A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma.
Cascón A; Ruiz-Llorente S; Rodríguez-Perales S; Honrado E; Martínez-Ramírez A; Letón R; Montero-Conde C; Benítez J; Dopazo J; Cigudosa JC; Robledo M
Genes Chromosomes Cancer; 2005 Mar; 42(3):260-8. PubMed ID: 15609347
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
